Skip to content
2000
Volume 2, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007
side by side viewer icon HTML

Abstract

Over the past few centuries, life-saving tools have been extensively used across the globe. The use of medical devices has increased adverse events associated with them. Materiovigilance is the process of identifying, collecting, reporting, and examining unfavorable events connected to medical devices in order to prevent the recurrence of such occurrences. Several countries keep an eye on medical products once they are commercialized. Other nations with similar programs include France, Australia, and the United Kingdom, in addition to the Medical Device Reporting (MDR) programme in the United States. This article addressed how some types of medical equipment might be dangerous and how a Materiovigilance programme is essential.

This page provides information about how to report adverse reactions to these medical devices, as well as what they are.

In many countries, post-marketing surveillance for medications has been initiated but is not as reliable and advanced as it is today. By monitoring adverse events related to medical devices, generating safety data, educating stakeholders, and recommending appropriate procedures and interventions, the Indian Pharmacopeia Commission established the committee on July 6, 2015.

Monitoring adverse events related to medical device usage can increase patient safety. On the basis of safety data gathered and generated, the Central Drugs Standard Control Organization (CDSCO) will make recommendations about the safe use of medical devices in the Indian population.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cis/10.2174/012210299X282463240118113902
2024-02-26
2025-05-03
The full text of this item is not currently available.

References

  1. BassetL. LassaleB. SuccamieleL. Moya-MacchiM. [Intravenous lines in transfusion and their medical devices].Transfus. Clin. Biol.201825427628010.1016/j.tracli.2018.08.00330172562
    [Google Scholar]
  2. BecharH. AttjiouiH. MimouniH. IsmailiR. TebaaA. BelahcenJ. RahaliY. Materiovigilance in health centers: The role of notifiers to ensure safer use of medical devices.Ann. Pharm. Fr.202280330131110.1016/j.pharma.2021.09.00334571010
    [Google Scholar]
  3. BerotV. BernigaudC. FerchiouA. Ingen-Housz-OroS. HüeS. AjzenbergC. ThomasS. Wieliczko-DuparcE. BillaudE. Ait-AmmarN. OrtonneN. BotterelF. ChosidowO. Extensive cutaneous and muscular mucormycosis complicating insulin pump treatment.J. Eur. Acad. Dermatol. Venereol.2020349e486e48910.1111/jdv.1640632242983
    [Google Scholar]
  4. ChefchaouniA.C. OuedraogoJ.M. BecharH. BelahcenM.J. RahaliY. Retrospective analysis of failures of ambulatory elastomeric pumps containing 5-FU in a hospital pharmacy unit.J. Oncol. Pharm. Pract.202329112512910.1177/1078155221106029034783287
    [Google Scholar]
  5. MeherB. Materiovigilance: An Indian perspective.Perspect. Clin. Res.20189417517810.4103/picr.PICR_26_1830319948
    [Google Scholar]
  6. MeherB. PadhyB. SrinivasanA. MohantyR. Awareness, attitude, and practice of materiovigilance among medical professionals at a tertiary care institute of national importance: A cross-sectional study.Perspect. Clin. Res.2022132949810.4103/picr.PICR_187_1935573456
    [Google Scholar]
  7. JoshiD. SharmaI. GuptaS. SinghT.G. DhimanS. PrasharA. GulatiM. KumarB. VishwasS. ChellappanD.K. GuptaG. JhaN.K. GuptaP.K. NegiP. DuaK. SinghS.K. A global comparison of implementation and effectiveness of materiovigilance program: Overview of regulations.Environ. Sci. Pollut. Res. Int.20212842596085962910.1007/s11356‑021‑16345‑534515931
    [Google Scholar]
  8. KalaiselvanV. SaxenaR. Intraocular devices associated adverse events reporting system in India.Indian J. Ophthalmol.202068112343234510.4103/ijo.IJO_298_2033120612
    [Google Scholar]
  9. KalaiselvanV. TripathiS.K. PrakashJ. Materiovigilance Programme of India: A scheme to assure cardiovascular devices safety surveillance.Indian Heart J.202072431631810.1016/j.ihj.2020.06.00932861393
    [Google Scholar]
  10. Sharifi-RadA. MehrzadJ. DarroudiM. SaberiM.R. ChamaniJ. Oil-in-water nanoemulsions comprising Berberine in olive oil: biological activities, binding mechanisms to human serum albumin or holo-transferrin and QMMD simulations.J. Biomol. Struct. Dyn.20213931029104310.1080/07391102.2020.172456832000592
    [Google Scholar]
  11. TaheriR. HamzkanluN. RezvaniY. NiroumandS. SamandarF. Amiri-TehranizadehZ. SaberiM.R. ChamaniJ. Exploring the HSA/DNA/lung cancer cells binding behavior of p-Synephrine, a naturally occurring phenyl ethanol amine with anti-adipogenic activity: multi spectroscopic, molecular dynamic and cellular approaches.J. Mol. Liq.202236812082610.1016/j.molliq.2022.120826
    [Google Scholar]
  12. Moosavi-MovahediA.A. GolchinA.R. NazariK. ChamaniJ. SabouryA.A. BathaieS.Z. Tangestani-NejadS. Microcalorimetry, energetics and binding studies of DNA–dimethyltin dichloride complexes.Thermochim. Acta2004414223324110.1016/j.tca.2004.01.007
    [Google Scholar]
  13. Ezazi-ToroghiS. SalarinejadS. Kamkar-VatanparastM. MokaberiP. Amiri-TehranizadehZ. SaberiM.R. ChamaniJ. Understanding the binding behavior of Malathion with calf thymus DNA by spectroscopic, cell viability and molecular dynamics simulation techniques: Binary and ternary systems comparison.J. Biomol. Struct. Dyn.20234194180419310.1080/07391102.2022.206491435437091
    [Google Scholar]
  14. RayA. NajmiA. KaoreS. SadasivamB. Role of materiovigilance in COVID era: An update.J. Family Med. Prim. Care20211072722272310.4103/jfmpc.jfmpc_2499_2034568165
    [Google Scholar]
  15. SivagourounadinK. RajendranP. RavichandranM. Knowledge, attitude, and practice of materiovigilance among nurses at a tertiary care hospital in South India: A cross-sectional study.J. Pharm. Bioallied Sci.202214316216710.4103/jpbs.jpbs_274_2136506730
    [Google Scholar]
  16. PerrotJ.L. BeyensM.N. VallardA. MagnéN. CinottiE. [Will France ever have a radio-vigilance office?].Bull. Cancer2019106121067106910.1016/j.bulcan.2019.05.00731350014
    [Google Scholar]
  17. RastogiS. ShuklaS. KalaivaniM. SinghG.N. Peptide-based therapeutics: Quality specifications, regulatory considerations, and prospects.Drug Discov. Today201924114816210.1016/j.drudis.2018.10.00230296551
    [Google Scholar]
  18. ShuklaS. GuptaM. PanditS. ThomsonM. ShivhareA. KalaiselvanV. SinghG.N. Implementation of adverse event reporting for medical devices, India.Bull. World Health Organ.202098320621110.2471/BLT.19.23278532132755
    [Google Scholar]
  19. SaifuddinP.K. TandonM. KalaiselvanV. SuroyB. PattanshettiV. PrakashA. MedhiB. Materiovigilance programme of india: Current status and way forward.Indian J. Pharmacol.202254322122535848694
    [Google Scholar]
  20. Sumersingh RajputD. GalibR. KalaiselvanV. Ziaur RahmanS. Manoj NesariT. Ancient wisdom of ayurveda vis-à-vis contemporary aspect of materiovigilance.J. Ayurveda Integr. Med.202213310059310.1016/j.jaim.2022.10059335849968
    [Google Scholar]
  21. MedhiB. SinghS. ChandelS. SarmaP. ReddyD.H. MishraA. KumarS. ThotaP. MuraliK. PrakashA. Biovigilance: A global perspective.Perspect. Clin. Res.201910415516210.4103/picr.PICR_89_1831649864
    [Google Scholar]
  22. DeoJ.K. RehanH.S. MehraP. Materiovigilance of unidirectional barbed and poliglecaprone 25 nonbarbed sutures used for intraoral incision closure: An open-label prospective study.Indian J. Pharmacol.202254534534836537403
    [Google Scholar]
  23. HerreroA. Gonot GaschardM. BouyabrineH. PerreyJ. PicotM.C. GuillonF. FabreJ.M. SoucheR. NavarroF. Comparative study of biological versus synthetic prostheses in the treatment of ventral hernias classified as grade II/III by the Ventral Hernia Working Group.J. Visc. Surg.202215929810710.1016/j.jviscsurg.2021.02.01134020911
    [Google Scholar]
  24. HodaF. VermaR. ArshadM. SiddiquiA.N. KhanM.A. AkhtarM. NajmiA.K. Materiovigilance: Concept, structure and emerging perspective for patient’s safety in India.Drug Res.202070942943610.1055/a‑1195‑194532746478
    [Google Scholar]
/content/journals/cis/10.2174/012210299X282463240118113902
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test